Harvard Heart Letter

Genetic help for a blood-thinner balancing act

The FDA is recommending a genetic test for people prescribed warfarin, to search for variants of certain genes that can affect the drug's effectiveness. But there is not enough evidence yet that the test makes using the drug safer.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In